Shiiaimedikaru
3540.TTSE STANDARD
Filed as C.I. MEDICAL CO.,LTD. (2022-08–2025-08)
Financials · Standalone
| Fiscal year ended | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥47.1bn | ¥43.1bn | ¥41.5bn | ¥40.0bn | ¥36.3bn | ¥28.3bn |
| Operating income | ¥1.5bn | ¥2.5bn | ¥3.8bn | ¥4.2bn | — | — |
| Ordinary income | ¥1.7bn | ¥3.0bn | ¥3.8bn | ¥4.6bn | ¥4.4bn | ¥2.1bn |
| Total assets | ¥43.2bn | ¥40.8bn | ¥29.5bn | ¥19.5bn | ¥18.3bn | ¥13.8bn |
| Net assets / equity | ¥20.8bn | ¥19.8bn | ¥18.1bn | ¥15.8bn | ¥13.5bn | ¥10.9bn |
| EPS (basic) | ¥23.34 | ¥38.97r | ¥51.65r | ¥58.53r | ¥54.3r | ¥151.28 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 11
| Period | Form | Figures |
|---|---|---|
| 2025-01-01 → 2025-06-30 | Half-year | 69 figures · EDINET |
| 2024-01-01 → 2024-12-31 | Annual | 200 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 67 figures · EDINET |
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 43 figures · EDINET |
| 2023-01-01 → 2023-12-31 | Annual | 197 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 45 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 69 figures · EDINET |
| 2023-01-01 → 2023-03-31 | Quarterly Q1 | 43 figures · EDINET |
| 2022-01-01 → 2022-12-31 | Annual | 197 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 45 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 69 figures · EDINET |
18 more reports are still being processed.
Segments · FY ended 2024-12
| Segment | External sales | Profit |
|---|---|---|
| Cimedical Business | ¥49.8bn | ¥2.0bn |
| Nissen Business | ¥17.7bn | ¥604m |
| Shirohato Business | — | — |
| Adjustments & eliminations | — | −¥151m |
| Total | ¥67.5bn | ¥2.6bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.